Evidence map›Paper›PMID 35224978›Full record

ArticlemSphere2022

Adenovirus 5 Vectors Expressing SARS-CoV-2 Proteins.

Scott Bachus, Nikolas Akkerman, Lauren Fulham, Drayson Graves, Caelan Stephanson, Harram Memon, Matthew S Miller, Peter Pelka

Abstract read
In one paragraph

Article in mSphere, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Scott BachusDepartment of Microbiology, University of Manitobagrid.21613.37, Winnipeg, Manitoba, Canada.
Nikolas Akkerman *Department of Microbiology, University of Manitobagrid.21613.37, Winnipeg, Manitoba, Canada.
Lauren Fulham *Department of Microbiology, University of Manitobagrid.21613.37, Winnipeg, Manitoba, Canada.
Drayson Graves *Department of Microbiology, University of Manitobagrid.21613.37, Winnipeg, Manitoba, Canada.
Caelan StephansonDepartment of Microbiology, University of Manitobagrid.21613.37, Winnipeg, Manitoba, Canada.
Harram MemonDepartment of Microbiology, University of Manitobagrid.21613.37, Winnipeg, Manitoba, Canada.
Matthew S MillerMichael G. DeGroote Institute for Infectious Disease Research, McMaster Universitygrid.25073.33, Hamilton, Ontario, Canada.
Peter PelkaDepartment of Microbiology, University of Manitobagrid.21613.37, Winnipeg, Manitoba, Canada.ORCID 0000-0003-0099-0422

Funding

CIHR PJT-166198CIHR PJT-173376
6 · The paper itself

Abstract

SARS-CoV-2 coronavirus is a recently identified novel coronavirus that is the causative agent of the COVID-19 pandemic that began in 2020. An intense research effort has been undertaken by the research community in order to better understand the molecular etiology of this virus and its mechanisms of host cell subjugation and immune system evasion. To facilitate further research into the SARS-CoV-2 coronavirus we have generated adenovirus 5-based viral vectors that express SARS-CoV-2 proteins-S, N, E, NSP7, NSP8, and NSP12 as hemagglutinin (HA)-tagged and untagged variants. We have also engineered two additional viruses that express the S protein receptor binding domain and a fusion of the receptor binding domain to the N protein. We show that these vectors are expressed in several different cell lines by Western blotting and real-time quantitative reverse transcriptase (qRT-PCR), we evaluate the subcellular localization of these viral proteins, and we show that these coronavirus proteins bind to a variety of cellular targets. The flexibility of adenovirus vectors allows them to be used in a variety of cell models and, importantly, in animal models as well.

Indexed as

COVID-19SARS-CoV-2AdenoviridaeAnimalsHumansPandemicsViral ProteinsViral ProteinsadenovirusCOVID-19SARS-CoV-2viral vectors

Identifiers

PMID35224978
PMCPMC9044955

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.